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Abstract
©  2017  Sharafutdinov,  Trizna,  Baidamshina,  Ryzhikova,  Sibgatullina,  Khabibrakhmanova,
Latypova, Kurbangalieva,Rozhina, Klinger-Strobel, Fakhrullin, Pletz, Bo gachev, Kayumov and
Makarewicz. The gram-positive opportunistic bacterium Staphylococcus aureus is one of the
most common causatives of a variety of diseases including skin and skin structure infection or
nosocomial catheter-associated infections. The biofilm formation that is an important virulence
factor  of  this  microorganism  renders  the  antibiotic  therapy  ineffective,  because  biofilm-
embedded bacteria exhibit strongly increased tolerance to antimicrobials. Here, we describe a
novel 3-chloro-5(S)-[(1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy]-4-[4-methylphenylsulfonyl] -
2(5H)-furanone (F105), possessing a sulfonyl group and l-menthol moiety. Minimal inhibitory and
bactericidal concentration values (MIC and MBC) of F105 were 10 and 40 mg/L, respectively,
suggesting  F105  biocidal  properties.  F105  exhibits  pronounced  activity  against  biofilm-
embedded S. aureus and increases the efficacy of aminoglycosides (amikacin, gentamicin, and
kanamycin) and benzalkonium chloride with fractional inhibitory concentration index values of
0.33-0.44 and 0.29, respectively, suggesting an alternative external treatment option, e.g., for
wound infections. Moreover, low concentrations (0.5-1.3 mg/L) of F105 reduced the MICs of
these antimicrobials twofold. By using confocal laser scanning microscopy and CFU counting, we
show explicitly that F105 also restores the antimicrobial activity of gentamicin and ampicillin
against S. aureus biofilms by several orders of magnitude. Biofilm structures were not destroyed
but sterilized, with embedded cells being almost completely killed at twofold MBC. While F105 is
quite toxic (CC 50 /MBC ratio 0.2), our data suggest that the F105 chemotype might be a
promising starting point for the development of complex topical agents for combined anti-
staphylococcal biofilm-therapies restoring the efficacy of some antibiotics against difficult to
treat S. aureus biofilm.
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